Annette Lasham

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. doi request reprint YB-1: oncoprotein, prognostic marker and therapeutic target?
    Annette Lasham
    Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
    Biochem J 449:11-23. 2013
  2. doi request reprint YB-1, the E2F pathway, and regulation of tumor cell growth
    Annette Lasham
    Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland, New Zealand
    J Natl Cancer Inst 104:133-46. 2012
  3. pmc The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing
    Mike Herbert
    Genesis Research and Development Corporation, Ltd, PO Box 50, Auckland 1140, New Zealand
    BMC Res Notes 4:148. 2011
  4. pmc Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer
    Cherie Blenkiron
    Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand Department of Surgery, University of Auckland, Auckland, New Zealand
    PLoS ONE 8:e80171. 2013
  5. pmc A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe
    Annette Lasham
    Genesis Research and Development Corporation Limited, Auckland, New Zealand
    Nucleic Acids Res 38:e19. 2010

Collaborators

Detail Information

Publications5

  1. doi request reprint YB-1: oncoprotein, prognostic marker and therapeutic target?
    Annette Lasham
    Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
    Biochem J 449:11-23. 2013
    ..We also argue that there is strong and sufficient evidence to suggest that YB-1 is an excellent molecular marker of cancer progression that could be used in the clinic, and that YB-1 could be a useful target for cancer therapy...
  2. doi request reprint YB-1, the E2F pathway, and regulation of tumor cell growth
    Annette Lasham
    Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland, New Zealand
    J Natl Cancer Inst 104:133-46. 2012
    ..Y-box binding factor 1 (YB-1) has been associated with prognosis in many tumor types. Reduced YB-1 expression inhibits tumor cell growth, but the mechanism is unclear...
  3. pmc The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing
    Mike Herbert
    Genesis Research and Development Corporation, Ltd, PO Box 50, Auckland 1140, New Zealand
    BMC Res Notes 4:148. 2011
    ..abstract:..
  4. pmc Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer
    Cherie Blenkiron
    Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand Department of Surgery, University of Auckland, Auckland, New Zealand
    PLoS ONE 8:e80171. 2013
    ....
  5. pmc A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe
    Annette Lasham
    Genesis Research and Development Corporation Limited, Auckland, New Zealand
    Nucleic Acids Res 38:e19. 2010
    ..With its sensitivity and specificity, this variation on the 5'RACE method should prove a useful tool to detect mRNA cleavage and corroborate knockdown studies following siRNA use in vivo...